These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 10711857)

  • 21. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
    D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H
    Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children.
    La Grutta S; Nicolini G; Capristo C; Bellodi SC; Rossi GA
    Monaldi Arch Chest Dis; 2007 Mar; 67(1):30-8. PubMed ID: 17564282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term management of asthma in children: effectiveness of inhaled corticosteroids compared to other medications.
    National Asthma Education and Prevention Program
    J Allergy Clin Immunol; 2002 Nov; 110(5 Suppl):S147-60. PubMed ID: 12518556
    [No Abstract]   [Full Text] [Related]  

  • 24. [Inhaled antiasthmatics in children. How to choose?].
    Fleurence E; de Blic J
    Arch Pediatr; 2000 Mar; 7(3):297-301. PubMed ID: 10761609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
    Ankerst J
    J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing growth effects of inhaled corticosteroids in children.
    Wolfgram PM; Allen DB
    J Allergy Clin Immunol; 2015 Dec; 136(6):1711-1712.e2. PubMed ID: 26654199
    [No Abstract]   [Full Text] [Related]  

  • 27. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
    LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for devices and choices.
    Everard ML
    J Aerosol Med; 2001; 14 Suppl 1():S59-64. PubMed ID: 11424895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of asthma therapy by a novel formoterol multidose dry powder inhaler.
    Moeller M; Grimmbacher S; Munzel U
    Arzneimittelforschung; 2008; 58(4):168-73. PubMed ID: 18540478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between prescribed and delivered doses of inhaled corticosteroids in adult asthmatics.
    Luskin AT; Bukstein D; Ben-Joseph R
    J Asthma; 2001 Dec; 38(8):645-55. PubMed ID: 11758893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of inhaled corticosteroids in pediatric asthma.
    Bisgaard H
    Pediatr Pulmonol Suppl; 1997 Sep; 15():27-33. PubMed ID: 9316099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study.
    Morice AH; Peterson S; Beckman O; Kukova Z
    Pulm Pharmacol Ther; 2008; 21(1):152-9. PubMed ID: 17376722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands.
    de Vries TW; Tobi H; Schirm E; van den Berg P; Duiverman EJ; de Jong-van den Berg LT
    Eur J Clin Pharmacol; 2006 Jan; 62(1):51-5. PubMed ID: 16365748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological management of children's asthma in general practice: findings from a community-based cross-sectional survey in Auckland, New Zealand.
    Crengle S; Robinson E; Grant C; Arroll B
    N Z Med J; 2011 Nov; 124(1346):44-56. PubMed ID: 22143852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhalation therapy: technological milestones in asthma treatment.
    Dalby R; Suman J
    Adv Drug Deliv Rev; 2003 Jul; 55(7):779-91. PubMed ID: 12842600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing symptoms and exacerbations in pediatric asthma.
    Verberne AA
    Pediatr Pulmonol Suppl; 1997 Sep; 15():46-50. PubMed ID: 9316102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting UK primary-care costs of managing patients with asthma over 5 years.
    Dasgupta R; Guest JF
    Pharmacoeconomics; 2003; 21(5):357-69. PubMed ID: 12627989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asthma symptoms and medication in the PIAMA birth cohort: evidence for under and overtreatment.
    Caudri D; Wijga AH; Smit HA; Koppelman GH; Kerkhof M; Hoekstra MO; Brunekreef B; de Jongste JC
    Pediatr Allergy Immunol; 2011 Nov; 22(7):652-9. PubMed ID: 21749462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-based asthma management.
    Kallstrom TJ
    Respir Care; 2004 Jul; 49(7):783-92. PubMed ID: 15222910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.